Analystreport

CollPlant Biotechnologies (NASDAQ:CLGN) had its "hold" rating reaffirmed by analysts at D. Boral Capital.

CollPlant Biotechnologies Ltd. - Ordinary Shares  (CLGN) 
US:NASDAQ Investor Relations: collplant.com/investor-relation